Hepatitis B News

 
 
  • New Antiviral Drug Promising Against HBV A hepatitis B virus core protein allosteric modulator appears safe and shows antiviral action in patients with chronic HBV infection, according to a small company-funded study.
  • ILC 2021 Protein Expression May Predict HBV DNA Suppression Protein expression patterns after treatment for HBV infections may help clinicians refine therapy.
  • Tri-antigenic Vaccine Prevents HBV Infection in Adults A tri-antigenic hepatitis B vaccine effectively prevented HBV infection in adults, was somewhat more effective than a mono-antigenic vaccine comparator, but had higher side effect rates in a phase 3 multicenter trial.
  • SciClone Pharma Tests Hepatitis Drug as COVID Vaccine Enhancer China's SciClone Pharmaceuticals has begun a clinical trial to test if its hepatitis B treatment Zadaxin helps to boost immunity provided by COVID-19 vaccines, it said on Monday.
  • COVID-19 Vaccine Response Lower in Kidney Dialysis Patients Most dialysis patients respond well to the Pfizer-BioNTech COVID-19 vaccine, but antibody levels are lower than those in healthy persons, shows the first study of its kind.
  • Coffee Could Be the Secret Weapon Against NAFLD "I do recommend at least two to three cups of coffee per day for my patients with NAFLD [nonalcoholic fatty liver disease]," said Manal F. Abdelmalek, MD, MPH.
  • Treatment Paradigm for Chronic HBV in Flux These days deciding when to stop targeted treatment for chronic hepatitis B is a bigger challenge than knowing when to start, Norah A. Terrault, MD, MPH, observed.
  • ART Likely Less Effective in Women With HIV Versus Other Chronic Viral Illnesses HIV-infected women who underwent assisted reproductive technology (ART) had a lower live birth rate than those with chronic hepatitis B or hepatitis C virus in a cohort study.
  • Women Report Worse Side Effects After COVID Vaccines Side effects tend to differ for men and women across a broad variety of vaccines, often due to hormones, genes, and the vaccine doses.
  • Alert Tocilizumab Scores FDA Approval for SSc-ILD Tocilizumab is the first biologic to be approved by the agency for adults with systemic sclerosis–associated interstitial lung disease, a rare, potentially life-threatening condition.
  • Bharat Biotech's COVID-19 Shot 81% Effective, Data Shows Bharat Biotech's vaccine showed 81% efficacy in preventing symptomatic COVID-19 in an interim analysis of a late-stage trial in India, a major boost for the shot shunned by some for lack of data.
  • Alert 2021 ACIP Adult Schedule Released The revised adult immunization schedule features a section on vaccination during the COVID-19 pandemic as well as recommended changes regarding several routine vaccinations.
  • Progress and Challenges in US Perinatal HBV Prevention Program The United States has made progress in identifying infants born to hepatitis B surface antigen (HBsAg)-positive women and getting them vaccinated.
  • CDC: 20% of People in the US Are Infected With an STD Among the more than 320 million people in the United States, there was a prevalence estimate of 67.6 million sexually transmitted infections at the time of assessment in 2018.
  • Eliminating Hepatitis by 2030: HHS Releases New Strategic Plan In an effort to counteract alarming trends in rising hepatitis infections, the HHS has developed and released its Viral Hepatitis National Strategic Plan 2021-2025.
  • USPSTF Reaffirms Advice on HBV Screening in High-Risk Individuals The USPSTF continues to recommend screening for hepatitis B virus in nonpregnant adolescents and adults at increased risk for HBV infection, concluding with 'moderate certainty' that such screening has moderate net benefit.
  • Pediatricians Want Kids To Be Part of COVID Vaccine Trials Although most pediatricians believe the eventual vaccination of children will be crucial to subduing the COVID-19 virus, they're split on how fast to move toward that, says Dr James Campbell.
  • AASLD 2020 Aspirin and Statins in Chronic Hepatitis B: It's Complicated Statins play a bigger part than aspirin in reducing risk for hepatocellular carcinoma in patients with hepatitis B, new research shows, and cirrhosis seems to cancel any beneficial effect of aspirin.
  • ANAC 2020 HIV PrEP Prescriptions Often Go Unfilled In communities most vulnerable to HIV, pre-exposure prophylaxis could fill the gap. But handing people a prescription isn't enough to make sure they are protected.
  • AASLD 2020 Mixed Outcomes in Tenofovir Trial for Chronic Hepatitis B Levels of surface antigen loss were low whether or not patients treated with tenofovir also received interferon, but some patients met criteria for inactive chronic disease after therapy withdrawal.